Entero Healthcare Solutions Ltd

BSE: 544122

29

total announcements

544122.BO · 15 min delayed

BSECompany Update27 Jul 2026

Entero Healthcare Solutions Ltd

Intimation regarding dispatch of letters to those Shareholders whose email addresses are not registered with Company/ Registrar and Share Transfer Agent/Depository Participant(s).

Entero Healthcare Solutions Ltd has dispatched letters to shareholders whose email addresses are not registered with the company or its registrar, providing a weblink to access the Annual Report for FY 2025-26. The company has also scheduled its 8th Annual General Meeting (AGM) to be held on August 19, 2026, through video conferencing.

Read more →📎 1 attachment
BSEOthersResults27 Jul 2026

Entero Healthcare Solutions Ltd

Annual Report for the financial year 2025-26

Entero Healthcare Solutions Ltd has announced its Annual Report for the financial year 2025-26, along with the Notice convening the 8th Annual General Meeting (AGM). The report highlights the company's performance, financial statements, and corporate governance report. The AGM will be held on August 19, 2026, through video conferencing.

Read more →📎 1 attachment
BSEAGM/EGM27 Jul 2026

Entero Healthcare Solutions Ltd

The 8th Annual General Meeting of the Members of Entero Healthcare Solutions Limited is scheduled to be held on Wednesday, August 19, 2026, at 12:30 p.m. (IST) through Video Conferencing/Other ....

Entero Healthcare Solutions Ltd has scheduled its 8th Annual General Meeting (AGM) on August 19, 2026, through video conferencing. The company has dispatched its annual report for the financial year 2025-26, along with the AGM notice, to its members via email and made it available on its website.

Read more →📎 1 attachment
BSEInsider Trading / SAST23 Jun 2026

Entero Healthcare Solutions Ltd

Intimation of Closure of Trading Window

Entero Healthcare Solutions Ltd has announced the closure of its trading window for designated persons and their immediate relatives. The window will be closed from July 01, 2026, until 48 hours after the company declares its unaudited financial results for the quarter ended June 30, 2026. This is a standard compliance measure in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, to prevent insider trading. The date for the Board Meeting to approve these results will be intimated subsequently.

Read more →📎 1 attachment
← PreviousPage 2 of 2